Related references
Note: Only part of the references are listed.Targeting inflammation by modulating the Jun/AP-1 pathway
Helia B. Schonthaler et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Integrated Approaches Reveal Determinants of Genome-wide Binding and Function of the Transcription Factor Pho4
Xu Zhou et al.
MOLECULAR CELL (2011)
Transcription Factor AP1 Potentiates Chromatin Accessibility and Glucocorticoid Receptor Binding
Simon C. Biddie et al.
MOLECULAR CELL (2011)
AP-1-The Jun proteins: Oncogenes or tumor suppressors in disguise?
Eitan Shaulian
CELLULAR SIGNALLING (2010)
Growth factor stimulation induces a distinct ERα cistrome underlying breast cancer endocrine resistance
Mathieu Lupien et al.
GENES & DEVELOPMENT (2010)
p53 Binding to Nucleosomal DNA Depends on the Rotational Positioning of DNA Response Element
Geetaram Sahu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Genome-Wide Analysis of Estrogen Receptor α DNA Binding and Tethering Mechanisms Identifies Runx1 as a Novel Tethering Factor in Receptor-Mediated Transcriptional Activation
Joshua D. Stender et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Crosstalk between sumoylation and acetylation regulates p53-dependent chromatin transcription and DNA binding
Shwu-Yuan Wu et al.
EMBO JOURNAL (2009)
Chromatin Adaptor Brd4 Modulates E2 Transcription Activity and Protein Stability
A-Young Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
One-step affinity tag purification of full-length recombinant human AP-1 complexes from bacterial inclusion bodies using a polycistronic expression system
Wei-Ming Wang et al.
PROTEIN EXPRESSION AND PURIFICATION (2008)
Deciphering AP-1 function in tumorigenesis - Fra-ternizing on target promoters
Pasquale Verde et al.
CELL CYCLE (2007)
Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family
Peter C. Hollenhorst et al.
GENES & DEVELOPMENT (2007)
Brd4 links chromatin targeting to HPV transcriptional silencing
Sh-Yuan Wu wu et al.
GENES & DEVELOPMENT (2006)
The general transcription machinery and general cofactors
Mary C. Thomas et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2006)
The Fos family of transcription factors and their role in tumourigenesis
K Milde-Langosch
EUROPEAN JOURNAL OF CANCER (2005)
E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation
MC Thomas et al.
MOLECULAR CELL (2005)
AP-1: A double-edged sword in tumorigenesis
R Eferl et al.
NATURE REVIEWS CANCER (2003)
HMG-I(Y) and the CBP/p300 coactivator are essential for human papillomavirus type 18 enhanceosome transcriptional activity
I Bouallaga et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Transcriptional activity among high and low risk human papillomavirus E2 proteins correlates with E2 DNA binding
SY Hou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Promoter specificity and biological activity of tethered AP-1 dimers
L Bakiri et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
AP-1 as a regulator of cell life and death
E Shaulian et al.
NATURE CELL BIOLOGY (2002)
A specific lysine in c-Jun is required for transcriptional repression by E1A and is acetylated by p300
RGJ Vries et al.
EMBO JOURNAL (2001)
Function and regulation of AP-1 subunits in skin physiology and pathology
P Angel et al.
ONCOGENE (2001)
Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity
Y Chinenov et al.
ONCOGENE (2001)
AP-1 in mouse development and tumorigenesis
W Jochum et al.
ONCOGENE (2001)
The mammalian Jun proteins: redundancy and specificity
F Mechta-Grigoriou et al.
ONCOGENE (2001)
Fra-1 replaces c-Fos-dependent functions in mice
A Fleischmann et al.
GENES & DEVELOPMENT (2000)
The many HATs of transcription coactivators
CE Brown et al.
TRENDS IN BIOCHEMICAL SCIENCES (2000)
Alleviation of human papillomavirus E2-mediated transcriptional repression via formation of a TATA binding protein (or TFIID)-TFIIB-RNA polymerase II-TFIIF preinitiation complex
SY Hou et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)